Anton G. Gueth

Anton G. Gueth

Amministratore Delegato presso
Evolution Life Science Partners
69 anni
Health Technology
Consumer Services
Commercial Services

Profilo

Anton G.
Gueth
is currently the Joint Managing Director at Evolution Life Science Partners since 2014 and the President & Managing Partner at Gueth Consulting LLC since 2003.
Previously, he served as the Chairman at Navidea Biopharmaceuticals, Inc. in 2016, Director-Alliance Management at Eli Lilly & Co., and Independent Director at Antares Pharma, Inc. from 2003 to 2022.
He also held positions as an Independent Director at Spectrum Pharmaceuticals, Inc. in 2012-2013, Director-Northern California Chapter at American Liver Foundation, Independent Director at Elevar Therapeutics, Inc., Director at Eqinox Healthcare France SASU, and Managing Director at Burrill Securities LLC.
Additionally, he served as the Managing Director-Gulf & Yemen Operations at Eli Lilly Saudi Arabia Ltd. and as a Director at iQone Healthcare Holding in 2012-2013.
Mr. Gueth also held positions as Vice President-Financial Planning & Treasury at PCS Health Systems, Inc. and Vice President-Business Development at NewBridge Pharmaceuticals FZ LLC.
He holds graduate degrees from Indiana University and the University of Giessen.

Posizioni attive di Anton G. Gueth

SocietàPosizioneInizio
Presidente 01/01/2003
Amministratore Delegato 01/10/2014

Precedenti posizioni note di Anton G. Gueth

SocietàPosizioneFine
ANTARES PHARMA, INC. Direttore/Membro del Consiglio 24/05/2022
NAVIDEA BIOPHARMACEUTICALS, INC. Presidente 31/03/2016
SPECTRUM PHARMACEUTICALS, INC. Direttore/Membro del Consiglio 28/06/2013
Direttore/Membro del Consiglio 01/06/2013
Direttore/Membro del Consiglio -
Vedi nel dettaglio l'esperienza di Anton G. Gueth

Formazione di Anton G. Gueth

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

57

Relazioni di 1° grado

16

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private16

Health Technology

Health Technology

Health Technology

Health Technology

Health Services

Consumer Services

Consumer Services

Commercial Services

Health Technology

Health Technology

Health Technology

Finance

Commercial Services

Finance

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Anton G. Gueth
-40%: Proroga eccezionale
g
:
:
ENTRA ORA